Mostrar el registro sencillo del ítem

dc.contributor.authorPérez Sayáns, Mario
dc.contributor.authorSuárez Peñaranda, Jose Manuel 
dc.contributor.authorQuintanilla, J. A. S.
dc.contributor.authorChamorro Petronacci, Cintia Micaela
dc.contributor.authorGarcía García, Abel 
dc.contributor.authorBlanco Carrión, Andrés
dc.contributor.authorGándara Vila, Pilar 
dc.contributor.authorSanchez, Y. G.
dc.date.accessioned2022-05-05T08:28:19Z
dc.date.available2022-05-05T08:28:19Z
dc.date.issued2020
dc.identifier.issn1746-160X
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/33050926es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/16681
dc.description.abstractBACKGROUND: Diagnosis of maxillary sinus pathology must include the clinical radiological study (CRS) and histopathological analysis. The aim of this study is 1) to describe the clinicopathological features of maxillary sinus lesions, obtained successively in a single medical centre over the last 10 years and 2) to determine the sensitivity and specificity for the diagnosis of malignant lesions based exclusively on the CRS. METHODS: It is a single-centre observational retrospective clinical study on patients who attended the University Hospital Complex of Santiago de Compostela (CHUS) with sinus pathologies during the period of 2009-2019. RESULTS: The sample consisted of 133 men (62.1%) and 81 women (37.9%), with an average age of 46.9 years (SD = 18.8). In terms of frequency, the most frequent pathology was the unspecified sinusitis (44.4%), followed by polyps (18.2%), malignant tumours (9.8%), inverting papilloma (7.5%), fungal sinusitis (4.7%), cysts (3.7%), benign tumours (2.3%), mucocele (2.3%) and other lesions (1.9%). Cysts and benign tumours were diagnosed earliest Vs malignant tumours (65.2 years (SD = 16.1)) were diagnosed the latest (p < 0.001). Based only on the CRS for malignancies, diagnostic indexes were 71.4% sensitivity and 97.9% specificity, with a Kappa value of 0.68 with (p < 0.001). CONCLUSION: Maxillary sinus pathology is very varied with therapeutic and prognostic repercussions. CRS is sometimes insufficient and histopathological confirmation is essential.en
dc.rightsAtribución 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.meshNasal Polyps*
dc.subject.meshMucocele*
dc.subject.meshMiddle Aged*
dc.subject.meshHumans*
dc.subject.meshMaxillary Sinus Neoplasms*
dc.subject.meshTomography*
dc.subject.meshRetrospective Studies*
dc.titleClinicopathological features of 214 maxillary sinus pathologies. A ten-year single-centre retrospective clinical studyen
dc.typeJournal Articlees
dc.authorsophosPerez-Sayans, M.;Penaranda, J. M. S.;Quintanilla, J. A. S.;Petronacci, C. M. C.;Garcia, A. G.;Carrion, A. B.;Vila, P. G.;Sanchez, Y. G.
dc.identifier.doi10.1186/s13005-020-00239-x
dc.identifier.pmid33050926
dc.identifier.sophos39876
dc.issue.number1es
dc.journal.titleHead & face medicinees
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago de Compostela - Complexo Hospitalario Universitario de Santiago de Compostela::Anatomía Patolóxicaes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago de Compostela - Complexo Hospitalario Universitario de Santiago de Compostela::Cirurxía Maxilofaciales
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)es
dc.page.initial24es
dc.rights.accessRightsopenAccess
dc.subject.decsneoplasias del seno maxilar*
dc.subject.decsestudios retrospectivos*
dc.subject.decsmediana edad*
dc.subject.decshumanos*
dc.subject.decsmucocele*
dc.subject.decstomografía*
dc.subject.decspólipos nasales*
dc.subject.keywordCHUSes
dc.subject.keywordIDISes
dc.typefidesArtículo Originales
dc.typesophosArtículo Originales
dc.volume.number16es


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional